MASHINIi

NextCure, Inc..

NXTC.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

NextCure, Inc. is a biopharmaceutical company focused on discovering and developing immunomedicines to treat cancer and other immune-related diseases. The company's primary focus is on understanding the interactions between the immune system and cancer, identifying novel immune checkpoints, and deve...Show More

Ethical Profile

Mixed.

NextCure, Inc. (NXTC.US) is a biopharmaceutical company focused on developing immunomedicines for cancer, Alzheimer's, and bone diseases, addressing significant unmet medical needs. While its core mission aligns with 'Better Health for All,' critics point to potential challenges regarding product accessibility and affordability if therapies are priced prohibitively. The company's drug development process, a standard industry practice, relies on animal testing. On the environmental front, NextCure reduced laboratory waste by 22% in 2023, with a projected 25% reduction in 2024. Its healthcare focus inherently supports 'No War, No Weapons.' Overall, NextCure receives a mixed ethical rating.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products-40
-100100

Better Health for All

0

No evidence available to assess NextCure, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess NextCure, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

No evidence available to assess NextCure, Inc. on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No evidence available to assess NextCure, Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

No evidence available to assess NextCure, Inc. on Honest & Fair Business.

Kind to Animals

0

No relevant information regarding NextCure, Inc.'s practices or policies related to animal welfare, animal testing, or animal-derived ingredients was found in the provided articles.

1
Therefore, no KPIs can be scored.

No War, No Weapons

0

NextCure, Inc. is a clinical-stage biopharmaceutical company focused on developing immunomedicines for cancer and other immune-related diseases.

1
The provided articles indicate that preclinical data on one of its antibodies (NC605) was presented at the 2023 Military Health System Research Symposium, with potential application to Veterans and military personnel for bone loss.
2
However, this is a health-related research presentation and does not constitute evidence of revenue from arms or defense contracts, investment in dual-use military technology, or any other direct association with arms manufacturing, military contracts, or conflict facilitation. No other information regarding the company's involvement in any activities related to the 'No War, No Weapons' value is available in the provided articles.

Planet-Friendly Business

0

Sustainability data for NextCure, Inc. is largely unavailable across the provided articles.

1
No specific, quantifiable evidence was found for any of the Planet-Friendly Business KPIs, including total greenhouse gas emissions, renewable energy use, water consumption, green building certifications, or climate-related financial disclosures.
2
While there was a reported 22% reduction in laboratory waste in 2023 and a 17% carbon emission reduction in 2023 (15.6 metric tons), these figures do not directly correspond to the specific metrics required by the rubric, such as waste diversion rate or total scope 1, 2, and 3 emissions.
3
The articles explicitly state that sustainability data is not available for the company for most metrics.
4

Respect for Cultures & Communities

0

No evidence available to assess NextCure, Inc. on Respect for Cultures & Communities.

Safe & Smart Tech

0

The company's Code of Business Conduct and Ethics, effective May 8, 2019, promotes compliance with applicable laws, rules, and regulations.

1
The company states it collects, maintains, and transmits confidential information to comply with cGMP and data integrity requirements.
2
It is subject to various regulations, including HIPAA, the federal Anti-Kickback Statute, and the Physician Payments Sunshine Act, as well as U.S. and foreign anti-corruption and trade laws.
3
However, no specific details on the extent or effectiveness of compliance with privacy regulations, beyond a general commitment and acknowledgment of being subject to them, are provided.

Zero Waste & Sustainable Products

-40

The company implements one waste reduction initiative by furnishing proxy materials via the internet, which reduces environmental impact and lowers the costs of printing and distributing these materials.

1

Own NextCure, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.